Healthcare of Ontario Pension Plan Trust Fund Buys Shares of 11,000 Balchem Co. (NASDAQ:BCPC)

Healthcare of Ontario Pension Plan Trust Fund acquired a new position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 11,000 shares of the basic materials company's stock, valued at approximately $1,693,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Bessemer Group Inc. lifted its stake in shares of Balchem by 568.9% during the 1st quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company's stock worth $47,000 after purchasing an additional 256 shares during the period. YHB Investment Advisors Inc. purchased a new stake in Balchem in the 1st quarter valued at about $69,000. GAMMA Investing LLC increased its stake in shares of Balchem by 18.0% during the 1st quarter. GAMMA Investing LLC now owns 473 shares of the basic materials company's stock valued at $73,000 after acquiring an additional 72 shares during the last quarter. TD Asset Management Inc purchased a new position in shares of Balchem during the 2nd quarter worth about $200,000. Finally, Heritage Family Offices LLP acquired a new stake in shares of Balchem in the second quarter worth approximately $206,000. Hedge funds and other institutional investors own 87.91% of the company's stock.

Balchem Stock Down 1.4 %

NASDAQ BCPC traded down $2.39 during trading hours on Monday, hitting $169.86. The company had a trading volume of 85,839 shares, compared to its average volume of 107,308. The firm's 50 day moving average is $171.05 and its 200 day moving average is $160.67. The company has a market capitalization of $5.51 billion, a price-to-earnings ratio of 47.98, a P/E/G ratio of 5.54 and a beta of 0.65. Balchem Co. has a fifty-two week low of $110.74 and a fifty-two week high of $186.03. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.83 and a quick ratio of 1.79.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its earnings results on Friday, July 26th. The basic materials company reported $0.98 EPS for the quarter, topping analysts' consensus estimates of $0.95 by $0.03. Balchem had a net margin of 12.52% and a return on equity of 10.94%. The business had revenue of $234.08 million for the quarter, compared to analysts' expectations of $241.26 million. Sell-side analysts anticipate that Balchem Co. will post 3.96 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. StockNews.com cut shares of Balchem from a "buy" rating to a "hold" rating in a research note on Monday, July 29th. HC Wainwright increased their target price on shares of Balchem from $170.00 to $185.00 and gave the stock a "buy" rating in a research report on Wednesday, July 31st.

Insider Activity

In other news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the business's stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $180.05, for a total value of $1,395,387.50. Following the completion of the sale, the senior vice president now owns 8,540 shares of the company's stock, valued at approximately $1,537,627. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.25% of the company's stock.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.